A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 674,764 shares of BSX stock, worth $61.5 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
674,764
Previous 611,693 10.31%
Holding current value
$61.5 Million
Previous $47.1 Million 20.04%
% of portfolio
0.08%
Previous 0.07%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$72.96 - $84.0 $4.6 Million - $5.3 Million
63,071 Added 10.31%
674,764 $56.5 Million
Q2 2024

Jul 19, 2024

BUY
$67.33 - $77.71 $5.23 Million - $6.04 Million
77,677 Added 14.55%
611,693 $47.1 Million
Q1 2024

Apr 22, 2024

BUY
$57.6 - $68.62 $1.52 Million - $1.82 Million
26,466 Added 5.21%
534,016 $36.6 Million
Q4 2023

Jan 16, 2024

BUY
$48.64 - $57.81 $716,126 - $851,136
14,723 Added 2.99%
507,550 $29.3 Million
Q3 2023

Oct 24, 2023

BUY
$50.19 - $54.68 $5.71 Million - $6.22 Million
113,832 Added 30.04%
492,827 $26 Million
Q2 2023

Jul 25, 2023

BUY
$49.72 - $54.64 $656,055 - $720,974
13,195 Added 3.61%
378,995 $20.5 Million
Q1 2023

Apr 14, 2023

BUY
$45.09 - $50.03 $3.02 Million - $3.35 Million
67,007 Added 22.43%
365,800 $18.3 Million
Q4 2022

Feb 08, 2023

BUY
$39.56 - $47.22 $2.95 Million - $3.53 Million
74,668 Added 33.32%
298,793 $13.8 Million
Q3 2022

Oct 25, 2022

BUY
$36.71 - $109.66 $436,151 - $1.3 Million
11,881 Added 5.6%
224,125 $8.68 Million
Q2 2022

Aug 12, 2022

BUY
$35.24 - $47.1 $359,941 - $481,079
10,214 Added 5.06%
212,244 $7.91 Million
Q1 2022

May 11, 2022

SELL
$40.9 - $45.1 $1.2 Million - $1.32 Million
-29,365 Reduced 12.69%
202,030 $8.95 Million
Q4 2021

Feb 08, 2022

SELL
$38.07 - $44.87 $6.68 Million - $7.87 Million
-175,378 Reduced 43.11%
231,395 $9.83 Million
Q3 2021

Nov 02, 2021

BUY
$41.23 - $45.88 $204,624 - $227,702
4,963 Added 1.24%
406,773 $17.7 Million
Q2 2021

Aug 11, 2021

BUY
$38.58 - $44.24 $96,758 - $110,953
2,508 Added 0.63%
401,810 $17.2 Million
Q1 2021

May 14, 2021

BUY
$35.27 - $39.67 $920,123 - $1.03 Million
26,088 Added 6.99%
399,302 $15.4 Million
Q4 2020

Feb 12, 2021

BUY
$33.15 - $41.97 $7.07 Million - $8.95 Million
213,276 Added 133.35%
373,214 $13.4 Million
Q3 2020

Nov 04, 2020

SELL
$34.44 - $42.23 $353,595 - $433,575
-10,267 Reduced 6.03%
159,938 $6.11 Million
Q2 2020

Jul 17, 2020

BUY
$30.19 - $39.11 $726,431 - $941,064
24,062 Added 16.46%
170,205 $5.98 Million
Q1 2020

Apr 21, 2020

SELL
$25.83 - $45.71 $1.2 Million - $2.12 Million
-46,295 Reduced 24.06%
146,143 $4.77 Million
Q4 2019

Feb 12, 2020

BUY
$37.87 - $45.37 $1.05 Million - $1.26 Million
27,680 Added 16.8%
192,438 $8.7 Million
Q3 2019

Nov 07, 2019

BUY
$40.31 - $43.45 $430,470 - $464,002
10,679 Added 6.93%
164,758 $6.7 Million
Q2 2019

Aug 06, 2019

BUY
$34.91 - $42.98 $102,216 - $125,845
2,928 Added 1.94%
154,079 $6.62 Million
Q1 2019

May 06, 2019

SELL
$32.91 - $40.75 $946,623 - $1.17 Million
-28,764 Reduced 15.99%
151,151 $5.8 Million
Q4 2018

Feb 11, 2019

BUY
$31.73 - $39.04 $2.45 Million - $3.01 Million
77,128 Added 75.04%
179,915 $6.36 Million
Q3 2018

Nov 14, 2018

BUY
$32.83 - $38.63 $693,238 - $815,711
21,116 Added 25.85%
102,787 $3.96 Million
Q2 2018

Jul 30, 2018

BUY
$26.84 - $34.32 $37,978 - $48,562
1,415 Added 1.76%
81,671 $2.67 Million
Q1 2018

Apr 16, 2018

BUY
$25.2 - $28.54 $722,736 - $818,527
28,680 Added 55.61%
80,256 $2.19 Million
Q4 2017

Feb 09, 2018

SELL
$24.79 - $29.8 $715,538 - $860,147
-28,864 Reduced 35.88%
51,576 $1.28 Million
Q3 2017

Oct 26, 2017

BUY
$26.26 - $29.17 $943,889 - $1.05 Million
35,944 Added 80.78%
80,440 $2.35 Million
Q2 2017

Aug 15, 2017

BUY
N/A
44,496
44,496 $1.23 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.